"Currently known three wearable programs Sanofi, Mefimmune, Amgem."
Mate that's the starting point from here on out imo. Add to that new Wearable customers and that is the roadmap, with the other programs we shall find out what they are to do going forward. I suspect a certain upfront of some sorts and possible licensing for the PFS programs, they are worth money to others who are already in the game and are able to sink the money into meeting those minimum amounts to manufacture, staff and then ramp.
The AI is an interesting one for me as I'm not sure if it goes with the PFS and Ocular all bundled up, lol, we wait for that!
- Forums
- ASX - By Stock
- UNS
- Strategic direction
Strategic direction, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online